Mainz Biomed B.V.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…
Medical - Diagnostics & Research
DE, Mainz [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Mainz Biomed B.V. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDMainz Biomed B.V. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Mainz Biomed B.V..
If you want to see a demo, head over to the financial segments of AAPL